Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beclometasone/formoterol treatment and withdrawal effects on lung inflammation in COPD
2012-001749-42Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of beclomethasone dipropionate and formoterol in chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB), sponsored by Policlinico Gemelli. Primary endpoint: Electronic nose response after steroid withdrawal. Started May 2012; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on 2012-001749-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001749-42.